Helixmith ranked among the top searched stocks on 5 days within the past month.
As of 2:31 PM on the 23rd, Helixmith is trading at 33,650 KRW, down 6.53% from the previous day. This represents a 38.93% decline compared to September 16. Helixmith is known as a specialized company developing new drugs focused on gene therapy.
Today, foreigners have tentatively been net buyers of 46,000 shares. Over the past 5 days, individual investors have net purchased 367,653 shares, while foreigners and institutions have net sold 302,565 shares and 73,437 shares, respectively.
On September 18, Helixmith became a market issue with the news of a 280 billion KRW rights offering, causing a 16% drop.


※ Source: AI Investment Assistant AI Rassiro
※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
![Clutching a Stolen Dior Bag, Saying "I Hate Being Poor but Real"... The Grotesque Con of a "Human Knockoff" [Slate]](https://cwcontent.asiae.co.kr/asiaresize/183/2026021902243444107_1771435474.jpg)
